Cellectis Valuation
| CMVLF Stock | USD 2.54 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. Cellectis SA shows a prevailing Real Value of $2.54 per share. The current price of the firm is $2.54. Our model approximates the value of Cellectis SA from analyzing the firm fundamentals such as Shares Outstanding of 55.59 M, operating margin of (6.01) %, and Return On Equity of -0.56 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Cellectis' price fluctuation is very steady at this time. Calculation of the real value of Cellectis SA is based on 3 months time horizon. Increasing Cellectis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cellectis pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cellectis SA. Since Cellectis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cellectis Pink Sheet. However, Cellectis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.54 | Real 2.54 | Hype 2.54 |
The real value of Cellectis Pink Sheet, also known as its intrinsic value, is the underlying worth of Cellectis SA Company, which is reflected in its stock price. It is based on Cellectis' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cellectis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cellectis SA helps investors to forecast how Cellectis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellectis more accurately as focusing exclusively on Cellectis' fundamentals will not take into account other important factors: Cellectis Total Value Analysis
Cellectis SA is currently expected to have takeover price of 82.79 M with market capitalization of 131.39 M, debt of 18.77 M, and cash on hands of 153.13 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cellectis fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
82.79 M | 131.39 M | 18.77 M | 153.13 M |
Cellectis Investor Information
The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellectis SA recorded a loss per share of 2.95. The entity had not issued any dividends in recent years. Based on the key indicators related to Cellectis' liquidity, profitability, solvency, and operating efficiency, Cellectis SA is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Cellectis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cellectis has an asset utilization ratio of 15.0 percent. This implies that the Company is making $0.15 for each dollar of assets. An increasing asset utilization means that Cellectis SA is more efficient with each dollar of assets it utilizes for everyday operations.Cellectis Ownership Allocation
Cellectis holds a total of 55.59 Million outstanding shares. Almost 90.2 percent of Cellectis outstanding shares are held by general public with 9.8 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cellectis Profitability Analysis
The company reported the revenue of 57.29 M. Net Loss for the year was (114.2 M) with profit before overhead, payroll, taxes, and interest of 34.18 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cellectis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cellectis and how it compares across the competition.
About Cellectis Valuation
The pink sheet valuation mechanism determines Cellectis' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cellectis. We calculate exposure to Cellectis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellectis's related companies.Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. Cellectis Romainvil operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 294 people.
8 Steps to conduct Cellectis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cellectis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cellectis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cellectis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cellectis' revenue streams: Identify Cellectis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cellectis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cellectis' growth potential: Evaluate Cellectis' management, business model, and growth potential.
- Determine Cellectis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cellectis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cellectis Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cellectis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 45.5 M | |
| Retained Earnings | -698.3 M |
Complementary Tools for Cellectis Pink Sheet analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |